ESLA
Estrella Immunopharma, Inc. - Common Stock (ESLA)
$31
About Estrella Immunopharma, Inc. - Common Stock (ESLA)
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
Details
Daily high
$0.34
Daily low
$0.30
Price at open
$0.33
52 Week High
$3.15
52 Week Low
$0.30
Market cap
14.3M
Dividend yield
-
Volume
319,066
Avg. volume
1.1M
P/E ratio
-1.30
Estrella Immunopharma, Inc. - Common Stock News
Details
Daily high
$0.34
Daily low
$0.30
Price at open
$0.33
52 Week High
$3.15
52 Week Low
$0.30
Market cap
14.3M
Dividend yield
-
Volume
319,066
Avg. volume
1.1M
P/E ratio
-1.30